We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+7.83%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$104B
AUM Growth
-$8.26B
Cap. Flow
-$18.3B
Cap. Flow %
-17.65%
Top 10 Hldgs %
9.93%
Holding
4,712
New
825
Increased
1,119
Reduced
1,773
Closed
730

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$862M
2
BIDU icon
Baidu
BIDU
+$752M
3
TME icon
Tencent Music
TME
+$426M
4
KO icon
Coca-Cola
KO
+$424M
5
NVDA icon
NVIDIA
NVDA
+$383M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$981M
2
WFC icon
Wells Fargo
WFC
+$673M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$574M
4
MRNA icon
Moderna
MRNA
+$442M
5
DD icon
DuPont de Nemours
DD
+$415M

Sector Composition

Rank Sector Weight
1 Technology 16.45%
2 Consumer Discretionary 10.49%
3 Communication Services 9.04%
4 Healthcare 8.89%
5 Financials 6.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BSN.WS
3401
DELISTED
Broadstone Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share
BSN.WS
$466K ﹤0.01%
+675,000
New +$829K
UMC icon
3402
United Microelectronic
UMC
$47.8B
$464K ﹤0.01%
50,896
+31,814
+167% +$294K
EVRI
3403
DELISTED
Everi Holdings
EVRI
$462K ﹤0.01%
32,730
-88,783
-73% -$1.26M
ICPT
3404
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$462K ﹤0.01%
20,000
– –
STOK icon
3405
Stoke Therapeutics
STOK
$2.09B
$461K ﹤0.01%
+11,857
New +$675K
VGR
3406
DELISTED
Vector Group Ltd.
VGR
$459K ﹤0.01%
+46,443
New +$441K
LUXA
3407
DELISTED
Lux Health Tech Acquisition Corp. Class A Common Stock
LUXA
$459K ﹤0.01%
+44,737
New +$497K
NEO icon
3408
NeoGenomics
NEO
$2.11B
$458K ﹤0.01%
9,497
-19,939
-68% -$1.04M
RVTY icon
3409
Revvity
RVTY
$13.7B
$457K ﹤0.01%
3,564
-9,187
-72% -$1.27M
AVTR icon
3410
Avantor
AVTR
$9.64B
$456K ﹤0.01%
+15,769
New +$455K
CARE icon
3411
Carter Bankshares
CARE
$719M
$456K ﹤0.01%
32,645
-14,200
-30% -$172K
IDYA icon
3412
IDEAYA Biosciences
IDYA
$3.86B
$453K ﹤0.01%
19,293
-9,904
-34% -$191K
WINA icon
3413
Winmark
WINA
$1.26B
$453K ﹤0.01%
2,431
+327
+16% +$59.4K
CENX icon
3414
Century Aluminum
CENX
$4.32B
$450K ﹤0.01%
25,472
+15,414
+153% +$220K
PCSB
3415
DELISTED
PCSB Financial Corporation
PCSB
$449K ﹤0.01%
27,003
-1,518
-5% -$24.9K
EGO icon
3416
Eldorado Gold
EGO
$12.1B
$448K ﹤0.01%
41,477
-220,438
-84% -$2.61M
UPWK icon
3417
PUT
Upwork
UPWK
$1.07B
$448K ﹤0.01%
+10,000
New +$462K
DCPH
3418
CALL
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$448K ﹤0.01%
10,000
– –
GOAC.WS
3419
DELISTED
GO Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock
GOAC.WS
$448K ﹤0.01%
+498,333
New +$755K
MDGL icon
3420
PUT
Madrigal Pharmaceuticals
MDGL
$11.8B
$444K ﹤0.01%
+3,800
New +$443K
NXTC icon
3421
NextCure
NXTC
$27M
$444K ﹤0.01%
3,696
+250
+7% +$36.2K
SB icon
3422
Safe Bulkers
SB
$881M
$444K ﹤0.01%
181,301
-50,658
-22% -$119K
UFI icon
3423
UNIFI
UFI
$142M
$444K ﹤0.01%
16,097
-41,470
-72% -$1M
STT icon
3424
State Street
STT
$52.4B
$443K ﹤0.01%
5,275
-224,279
-98% -$17.4M
KAI icon
3425
Kadant
KAI
$3.69B
$441K ﹤0.01%
2,384
-60
-2% -$9.62K
135 136
137
138 139

Similar funds

Vanguard Global Advisers
Vanguard Global Advisers Malvern, Pennsylvania $215B AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

David Shaw's Q1 2021 Portfolio in Review

As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

David Shaw withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, David Shaw opened a new position in Baidu worth $627M.

  • David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
  • David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
  • David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
  • David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
  • David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
  • David Shaw opened 825 new positions and closed 730 in Q1 2021.
  • David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.

Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.